Showing results (711-720 of 1,524) with videos related to
Sort By:
Pageof 153
CPT: Pharmacometrics & Systems Pharmacology|February 27, 2026
Population Pharmacokinetic-Pharmacodynamic Analysis of Zolpidem in Healthy Volunteers: Covariate Contributions to Variability in CNS ResponsesHyun Chul Kim, Jung Sunwoo, Seonghae Yoon, et al.CPT: Pharmacometrics & Systems Pharmacology|May 1, 2026
Population Pharmacokinetic Modeling and Exposure-Response Analyses of Nemtabrutinib in Patients With Hematologic MalignanciesChiara C Kemal, Thijs J Zweers, Elke H J Krekels, et al.CPT: Pharmacometrics & Systems Pharmacology|June 13, 2026
AI-Powered Lesion-Level Tumor Growth Inhibition Modeling Improves Model Stability and Prognostic Association With PFSAlan Liu, Chong Duan, Kevin Maresca, et al.CPT: Pharmacometrics & Systems Pharmacology|July 4, 2023
Seasonal influence on respiratory tract infection severity including COVID-19 quantified through Markov Chain modelingRob C van Wijk, Laurynas Mockeliunas, Caryn M Upton, et al.CPT: Pharmacometrics & Systems Pharmacology|June 17, 2023
Modeling tumor size dynamics based on real-world electronic health records and image data in advanced melanoma patients receiving immunotherapyPerrine Courlet, Daniel Abler, Monia Guidi, et al.CPT: Pharmacometrics & Systems Pharmacology|July 26, 2026
DDIapp-A Web-Based Application for Static Drug-Drug Interaction AssessmentHirotaka Watase, Sylvie Klieber, Yorgos M Psarellis, et al.CPT: Pharmacometrics & Systems Pharmacology|June 25, 2026
Accelerating Subcutaneous Drug Development: A Mechanistic Absorption Model for the Open Systems Pharmacology FrameworkMoriah Pellowe, Ilse Dubbelboer, Erik SjögrenCPT: Pharmacometrics & Systems Pharmacology|June 20, 2026
Development of an Agent-Based Model to Investigate Durability of Factor IX Activity in Hemophilia B Patients Treated With Etranacogene DezaparvovecYuezhe Li, Partha Nandy, Eric Jordie, et al.CPT: Pharmacometrics & Systems Pharmacology|June 27, 2026
Butorphanol Pharmacokinetics Across Species: Meta-Analysis Integrating Allometric Scaling and Minimal Physiologically Based Pharmacokinetic ModelingAhmed M Saeed, William J JuskoCPT: Pharmacometrics & Systems Pharmacology|June 30, 2026
Development and Use of a Population Pharmacokinetic Model for Characterizing the Pharmacokinetics of Vonoprazan in Pediatric PatientsDarcy J Mulford, Axel Facius, Galen Witt, et al.Pageof 153